Work

The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors

Year: 2022

Type: review

Source: Current Treatment Options in Oncology

DOI: 10.1007/s11864-022-01024-5

Authors: Susan E. Gueble, Juan C. Vasquez, Ranjit S. Bindra

Institution: Yale University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas

OpenAlex ID: W4306291451

FWCI: 0.182

Cites: 137

Cited by: 6

Related to: 10